SCIENTIFIC PROGRAMMohamed Farghaly Industry Sponsored Rashid Hall D Symposium - Novartis Industry...
Transcript of SCIENTIFIC PROGRAMMohamed Farghaly Industry Sponsored Rashid Hall D Symposium - Novartis Industry...
27 - 29 February 2020, Dubai, UAE
02
*Pro
gram
sub
ject
to c
hang
e
Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]
Industry Sponsored Rashid Hall A Symposium - Pfizer
Industry Sponsored Rashid Hall DSymposium - Abbott
DAY 1 – THURSDAY, 27 FEBRUARY 2020
08:00 - 08:45 Registration & Welcome Coffee
08:45 - 09:00 Introduction & Opening Remarks Fatheya AlAwadi, Emirates Diabetes Society President Iyad Ksseiry, Scientific Committee Chairman
09:00 - 09:30 Endocrine - Diabetes UAE Data Rashid Hall E Chairpersons: Abdulrazzaq Ali Al Madani | Khaled Al Dahmani
09:00 – 09:15 Vitamin B12 Replacement Post Bariatric Surgery Juma Alkaabi, UAE
09:15 – 09:30 Dubai Diabetes Registry – KPI’s Fatheya Alawadi, UAE
09:30 - 10:30 UAE Diabetes Society - Type 2 Diabetes Guidelines Rashid Hall E Chairpersons: Abdulrazzaq Ali Al Madani | Khaled Al Dahmani
09:30 – 09:35 Why do we need National Diabetes Guidelines? Fatheya Alawadi, UAE
09:35 – 09:50 Screening and Monitoring for Type 2 Diabetes Huda Ezzedine, UAE
09:50 – 10:05 Pharmacotherapy Overview Mohamed Hassanein, UAE
10:05 – 10:30 Q&A All Speakers
10:30 – 11:00 Opening Ceremony Rashid Hall E
11:00 – 11:30 Opening Exhibition, Coffee Break
11:30 – 13:00 Session 1: State of Art Lectures Rashid Hall E Chairpersons: Elham Al Amiri | Juma Al Kaabi
11:30 – 12:00 Primary Hyperparathyroidism: 7,000 Years of Progress Michael Levine, USA
12:00 – 12:30 Real World Evidence: The Utility in Evaluating Diabetes Treatments John Buse, USA
12:30 – 13:00 Diabetic Foot in 2020 Andrew Boulton, UK
13:00 – 14:15 Lunch Break / Poster Session / Product Theater
13:05 - 13:35 Industry Sponsored Symposium - Boehringer Ingelheim Rashid Hall D
13:40 – 14:10 Industry Sponsored Symposium - Sanofi Rashid Hall D
14:15 - 16:15
14:15 – 14:55
14:55 – 15:35
15:35 – 16:15
Session 2 - Rashid Hall D Endocrine Updates Chairpersons: Hussein Saadi | Jalal Nafach
What’s New in the Diagnosis and Treatment of HypopituitarismMargaret Wierman, USA
Thyroid Nodules, Evaluation and Management Douglass Ross, USA
New Insights into Assessment and Management of Polycystic Ovary SyndromeRicardo Azziz, USA
Early Identification of Peripheral Arterial Disease in DiabetesAndrew Boulton, UK
Growth Hormone Deficiency in ChildrenMichael Levine, USA
An Updated Review of Lipid-modifying TherapyStephane Heymans, Belgium
Metabolic Bone Diseases Case Scenarios Michael Levine, USA
Review of Recent Cardiovascular Outcome TrialsJohn Buse, USA
Prevention and Cure of Type 1Diabetes: Where are we StandingNow?Thomas Danne, Germany
Session 3 - Rashid Hall E Managing CV Risk in DiabetesChairpersons: Ahmed Hassoun | Abdullah Ben Nakhi
Session 4 - Rashid Hall A Pediatric EndocrinologyChairpersons: Asma Jassim | Elham Al Amiri
16:15 - 17:00
27 - 29 February 2020, Dubai, UAE
03
*Pro
gram
sub
ject
to c
hang
e
Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]
DAY 2 – Friday, 28 FEBRUARY 2020
07:30 - 08:30 Registration & Welcome Coffee
08:30 - 09:30 Session 5 - Diabetes Complications Rashid Hall E Chairpersons: Muhammad Farooqi | Mohamed Railey
08:30 - 09:00 Clinical Management of Diabetic Neuropathy Andrew Boulton, UK
09:00 – 09:30 Updates on Slowing Progression of Diabetic Kidney disease – George Bakris, USA Focus on Novel Therapies
09:30 – 10:00 Coffee Break / Product Theater
10:00 – 11:00 Session 6 - Androgens Rashid Hall E Chairpersons: Abdulrazzaq Ali Al Madani | Hussein Saadi
10:00 - 10:30 Does Everyone Have Low Testosterone? Margaret Wierman, USA 10:30 – 11:00 The Phenotype of Hirsute Women: Investigations and Management Ricardo Azziz, USA
11:00 - 12:00 Session 7 - State of Art Lectures Rashid Hall E Chairpersons: Mohammed Hassanein | Asma Jasim
11:00 - 11:30 Recent Advances in Treatment of Diabetes? John Buse, USA
11:30 – 12:00 Emerging Technologies in Diabetes Thomas Danne, Germany
12:00 - 14:15 Friday Prayer / Poster Session / Lunch Break / Product Theater
13:00 – 13:30 Industry Sponsored Symposium - Novo Nordisk Rashid Hall D
13:35- 14:05 Industry Sponsored Symposium - Lilly Rashid Hall D
14:15 – 16:15
14:15- 14:45
14:45 - 15:15
15:15 -15:45
15:45 -16:15
Session 8 - Rashid Hall D Women’s HealthChairpersons: Sara Suliman | Huda Ezzedine
The Objectives of Hyperprolac-tinemia TherapyJohn Wass, UK
Menopausal Hormone Therapy and AlternativesMargaret Wierman, USA
Infertility Treatment Related to Polycystic Ovary SyndromeRicardo Azziz, USA
Strategies in the Management ofType 1 versus Type 2 Diabetes inPregnancyNeda Rasouli, USA
Will Technology Change the Future of Diabetes?Osama Hamdy, USA
Should Metformin Remain the First Line of Therapy for Type 2 DiabetesNeda Rasouli, USA
Understanding the Link BetweenCardiovascular Disease and Diabetic Kidney DiseaseGeorge Bakris, USA
Adjunctive Therapy in Type 1 Diabetes: Anything Useful Beyond Insulin?John Buse, USA
Nutrition Reinvented in the Management of DiabetesOsama Hamdy, USA
Unusual Presentations of ThyroidDiseaseDouglas Ross, USA
Session 9 - Rashid Hall EHot Topics in DiabetesChairpersons: Glenn Matfin | Ahmed Hassoun
Session 10 - Rashid Hall A Meet the ExpertChairpersons: Aly Khalil | Mohamed Farghaly
Industry Sponsored Rashid Hall DSymposium - Novartis
Industry Sponsored Rashid Hall ASymposium - MSD 16:15 - 17:00
Diabetes Education / Nutrition Workshop - Rashid Hall DChairperson: Sara Adhami
10:00 - 11:00 Structured Diabetes
Education
Trudi Deakin, UK
27 - 29 February 2020, Dubai, UAE
04
*Pro
gram
sub
ject
to c
hang
e
Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]
DAY 3 – SATURDAY, 29 FEBRUARY 2020
07:30 - 08:30 Registration & Welcome Coffee
08:30 - 09:30 Session 11 – Thyroid Rashid Hall E Chairpersons: Abdulrazzaq Ali Al Madani | Alaaeldin Bashier
08:30 - 09:00 Update on Thyroid Disease in Pregnancy Neda Rasouli, USA
09:00 – 09:30 Low Risk Thyroid Cancer: Evidence, Expert Opinion and Common Sense Douglas Ross, USA
09:30 – 10:30 Oral Presentations
10:30 – 11:00 Coffee Break / Product Theater
11:00 – 13:00
11:00 – 11:30
11:30 – 12:00
12:00 – 12:30
12:30 – 13:00
Session 12 - Rashid Hall D Challenges and ControversiesChairpersons: Salah Abusnana | Khaled Al Dhamani
Congenital Adrenal Hyperplasia:A Patient-Centered ApproachMargaret Wierman, USA
Subclinical Thyroid Disease Douglas Ross, USA
Gestational Diabetes Mellitus: Glycemic Control and Maternal Prognosis.Neda Rasouli, USA
Acromegaly in 2019: More Clarity, Less ControversiesJohn Wass, UK
The Position of Nutrition andDiabetes Education in the GuidelinesTrudi Deakin, UK
Perspective on the New Blood Pressure GuidelinesGeorge Bakris, USA
Deciding on an SGLT2i or GLP1ra from Cardiology Perspective in ESC GuidelinesStephane Heymans, Belgium
Guide to Efficient Obesity Management in DiabetesOsama Hamdy, USA
Case Based Discussion of Difficult Pituitary CasesJohn Wass, UK
Resistant Hypertension: A Case Based PresentationGeorge Bakris, USA
Session 13 - Rashid Hall EGuidelinesChairpersons: Ossama Barakat | Muhammad Farooqi
Session 14 - Rashid Hall AMeet the ExpertChairpersons: Elamin Abdelgadir | Khadija Hafidh
13:00 - 14:00 Session 15: State of Art Lectures Rashid Hall E Chairpersons: Monira Alarouj | Mohammed Hassanein
13:00 - 13:30 Should Cardiologist be Familiar with Anti-Diabetes Medications? John Buse, USA
13:30 - 14:00 Should Endocrinologists Screen for Asymptomatic Cardiovascular Stephane Heymans, Disease and Heart Failure? Belgium
14:00 Closing Remarks
Diabetes Education / Nutrition Workshop - Rashid Hall DChairperson: Zeina Younes
8:30 - 9:30 Counting Carbohydrate /
Insulin Pump
Trudi Deakin, UK
INDUSTRY SYMPOSIUMS
13:05 - 13:35 - Rashid Hall DConsensus Recommendation for Management of Type 2 Diabetes Patients with Cardiovascular Disease
Speaker: Al Amin Ibrahim, UAE
13:40 – 14:10 - Rashid Hall D
Individualizing Diabetes Care – The Role of GLP1ra and Insulin Combination. What to Expect? Who Can Benefit?Speaker: Alaaeldin Bashir, UAE
16:15 - 16:35 - Rashid Hall A
Chairperson: Ahmed Hassoun, MD (UAE)
Global & Regional Recommendations for Adult Pneumococcal Vaccination – a View From a Public Health Prospective
Speaker: Faryal Khamis, MD (Oman)
16:35 - 16:55
The Risk of LRTIs in Adult Age Group with Diabetes – What do we know so far?
Speaker: Khadija Hafidh, MD (UAE)
16:55 - 17:00
Q&A - Closing remarks
16:15 - 17:00 - Rashid Hall D
Sensor-Based Data to Optimise Diabetes Care: Standardized Metrics and Real-World Data
Speaker: Mohammed Al-Khatib, UAE
DAY 1 – THURSDAY, 27 FEBRUARY 2020
Sponsored by
Sponsored by
Sponsored by
Sponsored by
27 - 29 February 2020, Dubai, UAE
05Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]
PRODUCT THEATER
11:10 - 11:25 Obesity Management: Are we on Right Track?Speaker: Rita Nawar
13:05 – 13:35 Trulicity Efficacy in RCTs and RWE Studies for Type 2 DiabetesSpeaker: Shenaz Sedat
13:40 – 14:10 The DUAL power to intensify diabetes treatmentSpeaker: John Buse
DAY 1 – THURSDAY, 27 FEBRUARY 2020
Sponsored by
Sponsored by
Sponsored by
INDUSTRY SYMPOSIUMS
27 - 29 February 2020, Dubai, UAE
06Congress Secretariat: MCI Middle East, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]
13:00 – 13:30 - Rashid Hall D
Expanding treatment options for Type 2 diabetes with Semaglutide: What to Expect from the New Kid on the BlockChairperson: Juma M. Al KaabiSpeaker: John Buse
13:35- 14:05 - Rashid Hall DTBC
Speaker: TBC
16:15 - 17:00 - Rashid Hall ATargeting the Core Defects Underlying Type 2 DiabetesSpeaker: Dr.Tarek Fiad, UAE
16:15 - 17:00 - Rashid Hall DVERIFYing the early treatment intensification in T2DMSpeaker: Dr. Mohamed Hassanein | Dr. Salah Abusnana, UAE
DAY 2 – FRIDAY, 28 FEBRUARY 2020
Sponsored by
Sponsored by
Sponsored by
Sponsored by
PRODUCT THEATER
13:00 - 13:30
Unpresedented Resistance and Revolutionary Combination for T2DM (Alogliptin, Pioglitzone)
Speaker: Jalal Nafach, UAE
09:35 - 09:50
Introducing One Touch Verio Reflect™ Meter “Moving From Monitoring to Mentoring”
Speaker: Amr Hamada
13:35 - 14:05
How Does Effective Titration Provide a Lasting Impact for T2DM Patients on Basal Insulin? A Case-Based Approach
Speaker: Bahaa Grace, UAE
DAY 2 – FRIDAY, 28 FEBRUARY 2020
Sponsored by
Sponsored by
Sponsored by